We are live on ! Find out more
Navalign LLC

Navalign LLC Portfolio holdings

AUM $437M Turnover 13.14%
1-Year Est. Return 12.96%
This Fund
S&P 500
This Quarter Est. Return
+6.48%
1 Year Est. Return
+12.96%
3 Year Est. Return
+58.66%
5 Year Est. Return
+60.55%
10 Year Est. Return
–
AUM
$236M
AUM Growth
+$10M
Cap. Flow
+$9.8M
Cap. Flow %
4.16%
Top 10 Hldgs %
53%
Holding
129
New
6
Increased
61
Reduced
47
Closed
6
Avg Time Held Equity + Options
0.2 years
Top 10 Avg Time Held Equity + Options
0.3 years
Top 20 Avg Time Held Equity + Options
0.2 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.3 years
Top 20 Avg Time Held Equity only
0.2 years
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AAPL icon
1
Apple
AAPL
$5.13T
$16.5M 6.99%
120,443
+532
+0.4% +$68.9K
2021 Q1
1 quarter
SCHP icon
2
Schwab US TIPS ETF
SCHP
$17.5B
$13.9M 5.87%
443,420
+29,262
+7% +$907K
2021 Q1
1 quarter
MTUM icon
3
iShares MSCI USA Momentum Factor ETF
MTUM
$16.5B
$13.5M 5.73%
312,328
+312,016
+100,005% +$13.2M
2021 Q1
1 quarter
SPYG icon
4
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.2B
$12.8M 5.43%
203,759
+749
+0.4% +$44.9K
2021 Q1
1 quarter
SPYV icon
5
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$38.5B
$12.6M 5.35%
319,981
-4,175
-1% -$165K
2021 Q1
1 quarter
VIGI icon
6
Vanguard International Dividend Appreciation ETF
VIGI
$9.2B
$11.8M 5.01%
135,244
+22,334
+20% +$1.93M
2021 Q1
1 quarter
VNQ icon
7
Vanguard Real Estate ETF
VNQ
$38.5B
$11.5M 4.85%
112,564
+6,945
+7% +$689K
2021 Q1
1 quarter
EMB icon
8
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13.8B
$11.2M 4.74%
99,623
+12,131
+14% +$1.35M
2021 Q1
1 quarter
IJR icon
9
iShares Core S&P Small-Cap ETF
IJR
$105B
$11.2M 4.73%
98,923
+8,933
+10% +$996K
2021 Q1
1 quarter
GUNR icon
10
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$6.75B
$10.2M 4.3%
265,357
+21,222
+9% +$821K
2021 Q1
1 quarter
AMGN icon
11
Amgen
AMGN
$250B
$5.86M 2.48%
24,024
-22
-0.1% -$5.41K
2021 Q1
1 quarter
BSV icon
12
Vanguard Short-Term Bond ETF
BSV
$46.5B
$4.43M 1.87%
54,101
-39,763
-42% -$3.27M
2021 Q1
1 quarter
SLYV icon
13
State Street SPDR S&P 600 Small Cap Value ETF
SLYV
$4.94B
$2.86M 1.21%
33,401
-11,341
-25% -$965K
2021 Q1
1 quarter
V icon
14
Visa
V
$796B
$2.58M 1.09%
11,010
+131
+1% +$29.9K
2021 Q1
1 quarter
JPST icon
15
JPMorgan Ultra-Short Income ETF
JPST
$42.3B
$2.52M 1.07%
49,591
+26,457
+114% +$1.34M
2021 Q1
1 quarter
META icon
16
Meta Platforms (Facebook)
META
$1.6T
$2.33M 0.99%
6,712
-33
-0.5% -$10.6K
2021 Q1
1 quarter
GOOGL icon
17
Alphabet (Google) Class A
GOOGL
$3.49T
$2.21M 0.94%
18,080
+60
+0.3% +$7.01K
2021 Q1
1 quarter
IEFA icon
18
iShares Core MSCI EAFE ETF
IEFA
$189B
$2.07M 0.88%
27,642
-35,274
-56% -$2.66M
2021 Q1
1 quarter
SLYG icon
19
State Street SPDR S&P 600 Small Cap Growth ETF
SLYG
$4.63B
$2.06M 0.87%
23,230
-7,816
-25% -$681K
2021 Q1
1 quarter
AMZN icon
20
Amazon
AMZN
$2.79T
$1.94M 0.82%
11,260
+240
+2% +$39.9K
2021 Q1
1 quarter
GNR icon
21
State Street SPDR S&P Global Natural Resources ETF
GNR
$5.15B
$1.88M 0.8%
35,540
-123
-0.3% -$6.6K
2021 Q1
1 quarter
CRM icon
22
Salesforce
CRM
$177B
$1.87M 0.79%
7,668
+214
+3% +$49.3K
2021 Q1
1 quarter
MSFT icon
23
Microsoft
MSFT
$3.85T
$1.82M 0.77%
6,729
+188
+3% +$47.8K
2021 Q1
1 quarter
ALLO icon
24
Allogene Therapeutics
ALLO
$280M
$1.68M 0.71%
+64,428
New +$1.84M
2021 Q2
0 quarters
AGG icon
25
iShares Core US Aggregate Bond ETF
AGG
$137B
$1.68M 0.71%
14,647
-18,951
-56% -$2.17M
2021 Q1
1 quarter

Similar funds

Navalign LLC's Q2 2021 Portfolio in Review

As of Q2 2021, Navalign LLC held 129 positions worth $236M, up 4.4% from $226M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Navalign LLC deployed $9.8M of net new capital in Q2 2021, opening 6 new positions and adding to 61 existing holdings. Its largest new stake was Allogene Therapeutics: 64,428 shares worth $1.68M.

By sector, the portfolio is most concentrated in Miscellaneous at 60% of assets, down from 63% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Bond ETF, an estimated $3.27M trimmed.

  • Navalign LLC's largest Q2 2021 buy was Allogene Therapeutics: 64,428 shares worth $1.68M.
  • Navalign LLC added most to iShares MSCI USA Momentum Factor ETF in Q2 2021, an estimated $13.2M increase.
  • Navalign LLC's biggest Q2 2021 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $3.27M.
  • Navalign LLC fully exited Vanguard Morningstar Total Stock Market ETF in Q2 2021, selling an estimated $1.07M.
  • Navalign LLC's ten largest holdings make up 53% of its $236M portfolio in Q2 2021.
  • Navalign LLC opened 6 new positions and closed 6 in Q2 2021.
  • Navalign LLC's portfolio value rose 4.4% quarter-over-quarter to $236M.

Based on Navalign LLC's 13F filing for Q2 2021, filed 13 Aug 2021.